Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial

BACKGROUND: This study is a pre-registration trial of generic duloxetine that was approved by the China Food and Drug Administration (approval number: 2006L01603). AIMS: Compare the treatment efficacy and safety of generic duloxetine to that of paroxetine in patients with major depressive disorders...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, Zhiyang, XU, Xiufeng, TAN, Qingrong, LI, Keqing, MA, Cui, XIE, Shiping, GAO, Chengge, WANG, Gang, LI, Huafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621288/
https://www.ncbi.nlm.nih.gov/pubmed/26549959
http://dx.doi.org/10.11919/j.issn.1002-0829.215064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621288/
https://www.ncbi.nlm.nih.gov/pubmed/26549959
http://dx.doi.org/10.11919/j.issn.1002-0829.215064

Ejemplares similares